10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $65,794 | -30.9% | 1,595 | -6.5% | 0.00% | -100.0% |
Q2 2023 | $95,263 | +29.0% | 1,706 | +28.9% | 0.00% | – |
Q1 2023 | $73,866 | +48.9% | 1,324 | -2.7% | 0.00% | – |
Q4 2022 | $49,595 | +24.0% | 1,361 | -2.2% | 0.00% | – |
Q3 2022 | $40,000 | -35.5% | 1,392 | +1.5% | 0.00% | – |
Q2 2022 | $62,000 | -49.2% | 1,371 | -14.6% | 0.00% | -100.0% |
Q1 2022 | $122,000 | -49.0% | 1,605 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $239,000 | 0.0% | 1,605 | -2.3% | 0.00% | 0.0% |
Q3 2021 | $239,000 | -30.9% | 1,643 | -7.0% | 0.00% | 0.0% |
Q2 2021 | $346,000 | +48.5% | 1,767 | +37.2% | 0.00% | 0.0% |
Q1 2021 | $233,000 | +14.2% | 1,288 | -10.7% | 0.00% | 0.0% |
Q4 2020 | $204,000 | +9.1% | 1,442 | -4.0% | 0.00% | 0.0% |
Q3 2020 | $187,000 | +40.6% | 1,502 | +0.9% | 0.00% | 0.0% |
Q2 2020 | $133,000 | – | 1,488 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |